title: [Profiles of cognitive and language impairment of logopenic and non-fluent variant of primary progressive aphasia].
abstract: OBJECTIVE
  To decipher the cognitive and linguistic feature of logopenic variant primary progressive aphasia (lv-PPA) and nonfluent variant primary progressive aphasia (nfv-PPA) and to explore the extent to which cognitive and language impairment contribute to the dysfunction of activity of daily living(ADL).
  
  
  METHODS
  Seven lv-PPA and five nfv-PPA were enrolled in memory clinic of Xuanwu Hospital, Capital Medical University from January 2015 to January 2016 accordig to the international consensus criteria for PPA and its three subtypes. 20 age-matched normal controls (NC) were included. Both the patients and the NC completed a battery of neuropsychological test, lingusitic test and brain magnetic resonance imaging. All the patients conducted (11)C Pittsburgh compound B (PiB) PET imaging.
  
  
  RESULTS
  Lv-PPA patients were characterized by deficits in lexical retrieval and long sentenses repetition, while nfv-PPA were with motor speech apraxia and phonetic distortion. Compared with nfv-PPA, lv-PPA patient displayed more severe cognitive deficit with younger onset of age (56±5 vs 61±5, P<0.05) , rapid decline of MMSE score within 1.5 years and pariental cortex dysfunctions such as ideomotor praxis, Gerstmann syndrome and contructional apraxia. Correlation analysis indicated that there was more significant association between pariental cortex dysfunction and ADL/mini-mental state examination(MMSE) than that of language deficit(r=-0.868, r=-0.922; r=0.312, r=-0.257). All seven lv-PPA were PiB-PET positive and five nfv-PPA were negative.
  
  
  CONCLUSIONS
  This study enriched the chinical and linguistic characterization of lv-PPA and nfv-PPA, which has implication for diagnosis, disease management and treatment for clinicians.
authors.affiliation: Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
authors.forename: D
authors.initials: D
authors.lastname: Li
authors.forename: L N
authors.initials: LN
authors.lastname: Zhao
authors.forename: H M
authors.initials: HM
authors.lastname: Jin
authors.forename: M
authors.initials: M
authors.lastname: Zhang
authors.forename: D M
authors.initials: DM
authors.lastname: Guo
authors.forename: Y Y
authors.initials: YY
authors.lastname: Yu
authors.forename: L Y
authors.initials: LY
authors.lastname: Wu
authors.forename: Y
authors.initials: Y
authors.lastname: Tang
authors.forename: F Y
authors.initials: FY
authors.lastname: Li
authors.forename: A H
authors.initials: AH
authors.lastname: Zhou
authors.forename: Y
authors.initials: Y
authors.lastname: Han
authors.forename: J P
authors.initials: JP
authors.lastname: Jia
mesh_terms: D000814:Aniline Compounds; D018888:Aphasia, Primary Progressive; D003071:Cognition; D003072:Cognition Disorders; D006801:Humans; D007802:Language; D008279:Magnetic Resonance Imaging; D008568:Memory; D009483:Neuropsychological Tests; D013844:Thiazoles
chemical_list: C475519:2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole; D000814:Aniline Compounds; D013844:Thiazoles